Evaluation of an Age-Friendly Health System: 4Ms Assessments and Outcomes in Hospitalized Older Adults
Justin Lam, Susan Kwiatek, Shahidul Islam, Mark Tursi, Christian Nouryan, Philip Solomon, Maria Carney, Edith Burns

TL;DR
This study evaluates how using a framework called 4Ms in hospitals affects outcomes for older adults, finding that those who received all 4Ms had fewer emergency visits and possibly better readmission rates.
Contribution
The study provides preliminary evidence on the impact of the 4Ms framework on outcomes in hospitalized older adults.
Findings
Patients who received all 4Ms had fewer 30-day ED visits and a trend toward lower readmissions.
Those receiving 4Ms were older and had lower mobility scores.
Higher mortality was observed in the 4Ms group, possibly due to greater illness burden.
Abstract
The Institute for Healthcare Improvement developed the 4Ms framework (What Matters Most/Medication/Mentation/Mobility) to facilitate Age-Friendly Health Systems (AFHS). Each M has evidence-based screening tools leading to improved outcomes among older adults. We report screening 4Ms vs. 1-3Ms outcomes for hospitalized adults aged ≥65 across hospitals in a large healthcare system. Demographics and clinical data abstracted manually from EMR and from 4Ms AFHS dashboard. Patients ≥65y/o admitted July-September 2024 to eight hospitals committed to care excellence. Outcomes: Length of stay (LOS), 30-day readmission, 30-day ED visits, mortality. Of 3,103 older adult admissions, 298 (9.6%) received all 4Ms and 2,805 received 1-3Ms. Median age: for 4Ms, 84 (IQR:76-90) and for 1-3Ms, 77 (IQR:71-84). Primary language was English for both. Median LOS: for 4Ms, 9 days (IQR:6-15) and for 1-3Ms, 9…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFrailty in Older Adults · Chronic Disease Management Strategies · Pharmaceutical Practices and Patient Outcomes
